(PR) Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix(TM) P-15 Peptide Enhanced Bone Graft

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of two back-to-back papers in Spine detailing 24-month ...

Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix(TM) P-15 Peptide Enhanced Bone Graft

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of two back-to-back papers in Spine detailing 24-month ...

Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today ...
Becker's Spine Review

Cerapedics’ PearlMatrix bone graft superior to local autograft: Study

A 24-month study of Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft found it had better time-to-fusion and clinical success than a local autograft, according to a Dec. 17 news release. Five ...
Opinion
Becker's Spine ReviewOpinion

Why CPT 62380 is now a barrier to patient access — and why it should be eliminated

For years, debate around endoscopic spine surgery centered on whether the technique was ready for broad adoption. Questions about safety, durability, and outcomes dominated discussions among surgeons, ...